Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Ordinary Shares, nominal value 0.05 GBP per share
-
Shares outstanding
-
84,213,667
-
Total 13F shares
-
3,954,155
-
Share change
-
+3,954,155
-
Total reported value
-
$46,085,000
-
Price per share
-
$11.66
-
Number of holders
-
9
-
Value change
-
+$46,085,000
-
Number of buys
-
9
Institutional Holders of Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) as of Q2 2017
As of 30 Jun 2017,
Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,954,155 shares.
The largest 9 holders included
Novo Holdings A/S, Vivo Capital, LLC, NEA Management Company, LLC, ORBIMED ADVISORS LLC, Foresite Capital Management III, LLC, Tekla Capital Management LLC, PERCEPTIVE ADVISORS LLC, FIL Ltd, and JANE STREET GROUP, LLC.
This page lists
9
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.